The Business of IVF: How Human Eggs Went from Simple Cells to a Valuable Commodity
By Catherine Waldby,
The Conversation
| 10. 03. 2019
I think they collected […] maybe, six eggs. I think we got four embryos out of that […] One was transferred and three were frozen. So, the fresh cycle didn’t work. Tried a frozen one, didn’t work. Went to try the third frozen and they told me that one didn’t survive unfreezing, so then we had one left and that didn’t work, so we had no embryos left. So we did a fresh egg cycle again, and they got even less this time […] So I was thinking this is all going to be wasting time. But […] I think they fertilised four eggs, and then there was only one viable one, which is my baby.
Eva, a teacher in her early 30s, describes in my recent book The Oocyte Economy: the Changing Meaning of Human Eggs, a very common experience for women who have fertility treatment.
Many women and couples, encouraged by success stories and marketing, hope their years of unsuccessful attempts to conceive a child naturally are over, and fertility treatment will work.
Assisted reproductive technologies cover a...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...